This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Completed
We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP:?18?and above
TRIAL STATUS:?Recruiting